TABLE III:
MAE(%) | ||||
Lesion/Organ | OSEM | Sequential | Truncation | End2end |
Lesion (3–356mL) | 32.5 ± 1.3 | 25.3 ± 1.3 | 24.9 ± 1.0 | 23.1 ± 1.8 |
Liver | 25.0 ± 0.1 | 18.7 ± 0.1 | 17.8 ± 1.3 | 15.6 ± 3.6 |
Healthy liver | 25.1 ± 0.2 | 23.8 ± 0.5 | 21.8 ± 1.2 | 19.4 ± 3.1 |
Lung | 88.4 ± 2.1 | 64.9 ± 1.6 | 58.3 ± 6.6 | 48.9 ± 8.4 |
NRMSE(%) | ||||
Lesion/Organ | OSEM | Sequential | Truncation | End2end |
Lesion (3–356mL) | 35.3 ± 1.5 | 29.6 ± 1.4 | 28.9 ± 1.1 | 27.8 ± 1.2 |
Liver | 29.9 ± 0.4 | 22.7 ± 0.1 | 22.1 ± 0.9 | 21.2 ± 1.5 |
Healthy liver | 31.6 ± 0.4 | 27.9 ± 0.3 | 27.0 ± 0.9 | 25.9 ± 2.0 |
Lung | 62.4 ± 1.3 | 59.2 ± 1.1 | 57.3 ± 3.0 | 55.6 ± 4.6 |